You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daratumumab

Showing 201 - 225 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma Trial in United States (drug,

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Anchorage, Alaska
  • +459 more
Dec 7, 2022

Newly Diagnosed Multiple Myeloma Trial in Spain (Lenalidomide., Carfilzomib, Bortezomib)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • A Coruña, Spain
  • +64 more
Mar 12, 2021

Multiple Myeloma Trial in Belgium, France, Netherlands (Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD), Bortezomib,

Active, not recruiting
  • Multiple Myeloma
  • Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD)
  • +2 more
  • Antwerp, Belgium
  • +106 more
Dec 3, 2020

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Plasma Cell Myeloma Trial in Columbus (Daratumumab)

Completed
Has Results
  • Plasma Cell Myeloma
  • Daratumumab
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 14, 2019

Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Lemzoparlimab
  • +4 more
  • Tucson, Arizona
  • +58 more
Jul 6, 2022

Smoldering Plasma Cell Myeloma Trial in United States (biological, drug, other)

Recruiting
  • Smoldering Plasma Cell Myeloma
  • Daratumumab
  • +4 more
  • Anchorage, Alaska
  • +595 more
Dec 7, 2022

Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer, Mismatch Repair Proficient Colorectal Cancer

Active, not recruiting
  • Microsatellite Unstable Colorectal Cancer
  • +3 more
  • Gilbert, Arizona
  • +31 more
Dec 21, 2021

Healthy Trial in Tempe (Daratumumab, Placebo, rHuPH20)

Completed
  • Healthy
  • Daratumumab
  • +2 more
  • Tempe, Arizona
    Celerion
Sep 4, 2019

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (ABBV-383, Dexamethasone, Lenalidomide)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Little Rock, Arkansas
  • +45 more
Jul 8, 2022

Multiple Myeloma in Relapse, Plasmacytoma, Daratumumab Trial in Seoul (Drug Combinations)

Unknown status
  • Multiple Myeloma in Relapse
  • +2 more
  • Drug Combinations
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 21, 2019

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Healthy Trial in Saint Petersburg (BCD-264, Darzalex)

Active, not recruiting
  • Healthy
  • Saint Petersburg, Russian Federation
  • +2 more
Jul 25, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Determine the Optimal Initial Therapy for Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • Non-Interventional Study
  • Scottsdale, Arizona
  • +3 more
Nov 22, 2023

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma Trial in Caen (Ixazomib and Daratumumab)

Recruiting
  • Multiple Myeloma
  • Ixazomib and Daratumumab
  • Caen, France
    CHU CAEN Dept of Hematology
Jul 5, 2019

NSCLC Trial in Worldwide (Atezolizumab, Daratumumab)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Loma Linda, California
  • +46 more
Nov 5, 2019

Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Modakafusp alfa
  • +5 more
  • Little Rock, Arkansas
  • +53 more
Jan 12, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Myeloma Multiple Trial in Siena (Daratumumab)

Recruiting
  • Myeloma Multiple
  • Daratumumab
  • Siena, Italy
    Azienda Ospedaliera Universitaria Senese
Jun 17, 2019

Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +126 more
Jan 10, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory Trial (Pomalidomide 4 mg every day in cycle 1,

Not yet recruiting
  • Multiple Myeloma in Relapse
  • +2 more
  • Pomalidomide 4 mg every day in cycle 1
  • +4 more
  • (no location specified)
Nov 16, 2022

Multiple Myeloma Trial in Australia, United Kingdom, United States (RO6870810, daratumumab)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +11 more
Feb 6, 2020

Multiple Myeloma Trial in France (Isatuximab, ASCT)

Recruiting
  • Multiple Myeloma
  • AMIENS Cedex 1, France
  • +67 more
Mar 28, 2022